BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Following Merck announcing their goal to phase out animal use 
 in their work\, Astellas and MIMETAS expanding their partnership in immun
 otherapeutic development\, and the domino effects across the field caused
  by the FDA Modernization Act 2.0\, 2023 has set an exciting precedent fo
 r the upcoming year. However\, the translation rates of oncology therapeu
 tics into the clinic remain at 20%\, proving there remains a large unmet 
 need for tools to support drug development efforts in a patient-specific 
 context at the preclinical and early translational levels.\n\nAt the 8th 
 Annual Tumor Models San Francisco Summit\, you will gain practical insigh
 ts into the latest updates across the West Coast and beyond through 25+ c
 ase studies that will empower your candidate selection workflows. Join us
  to learn from and meet pioneers in preclinical and translational oncolog
 y to accelerate your candidate's clinical translatability with optimized 
 efficiency\, and cost-effectiveness!\n\nWhat's in store?Discover the rati
 onale Amgen\, IGM Biosciences\, Rondo Therapeutics\, and more implement a
 cross their model selection criteria to empower you to streamline your mo
 del selection processes.\n\nRevolution Medicines spotlight the potential 
 of genetically engineered models to enhance the therapeutic potential of 
 RAS-targeted inhibitors\n\nUncover strategies to develop PDX models to su
 pport ADC studies at the preclinical stage through to preparation for an 
 IND filing with Sutro Biopharma\n\nArsenal Biosciences demonstrate the ap
 plications of tumor models in cell therapy program development across mul
 tiple cancer indications\n\nCharacterize the complexities of the componen
 ts of the tumor microenvironment by leveraging spatial biology and digita
 l pathology tools with Takeda\n
DTEND:20240201T170000
DTSTAMP:20260512T232257Z
DTSTART:20240130T090000
LOCATION:Grand Hyatt At SFO\, 55\, South Mcdonnell Road\, San Francisco\, 
 San Mateo County\, 94128\,
SEQUENCE:0
SUMMARY:Following Merck announcing their goal to phase out animal use in t
 heir work\, Astellas and MIMETAS expanding their partnership in immunothe
 rapeutic...
UID:608de7a0-1d14-43b3-8e41-a5cc81bd34c6
END:VEVENT
END:VCALENDAR
